Saxon Interests Inc. Makes New Investment in Bath & Body Works, Inc. $BBWI

Saxon Interests Inc. acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 53,627 shares of the company’s stock, valued at approximately $1,077,000.

Other institutional investors have also recently bought and sold shares of the company. Geneos Wealth Management Inc. boosted its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Danske Bank A S acquired a new stake in Bath & Body Works during the 3rd quarter worth about $39,000. Global Retirement Partners LLC acquired a new stake in Bath & Body Works during the 4th quarter worth about $31,000. Activest Wealth Management acquired a new stake in Bath & Body Works during the 4th quarter worth about $32,000. Finally, Advisory Services Network LLC acquired a new stake in Bath & Body Works during the 3rd quarter worth about $48,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Get Bath & Body Works alerts:

Bath & Body Works Stock Performance

BBWI opened at $19.40 on Friday. The business has a 50 day moving average price of $18.61 and a 200 day moving average price of $20.07. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $33.96. The firm has a market cap of $3.91 billion, a P/E ratio of 5.45, a price-to-earnings-growth ratio of 1.87 and a beta of 1.42.

Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. During the same period in the previous year, the company earned $0.49 EPS. The company’s revenue for the quarter was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, analysts anticipate that Bath & Body Works, Inc. will post 2.62 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Investors of record on Friday, June 5th will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.1%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s payout ratio is 22.47%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on BBWI. Barclays decreased their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research report on Thursday, May 28th. UBS Group decreased their price objective on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. Wells Fargo & Company reduced their price target on Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Finally, Telsey Advisory Group reduced their price target on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a report on Thursday, May 28th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $21.93.

View Our Latest Report on Bath & Body Works

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

See Also

• Five stocks we like better than Bath & Body Works
• SpaceX Rings the Bell and Shatters Every Record
• Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
• 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
• The 127-Gigawatt Problem: Why AI Needs Its Own Power

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.